Suzuken Co., Ltd.

TSE:9987 Stock Report

Market Cap: JP¥365.5b

Suzuken Past Earnings Performance

Past criteria checks 4/6

Suzuken has been growing earnings at an average annual rate of 5.8%, while the Healthcare industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 2.3% per year. Suzuken's return on equity is 7.8%, and it has net margins of 1.4%.

Key information

5.8%

Earnings growth rate

9.4%

EPS growth rate

Healthcare Industry Growth7.9%
Revenue growth rate2.3%
Return on equity7.8%
Net Margin1.4%
Next Earnings Update12 Feb 2025

Recent past performance updates

There Are Some Reasons To Suggest That Suzuken's (TSE:9987) Earnings Are A Poor Reflection Of Profitability

Nov 21
There Are Some Reasons To Suggest That Suzuken's (TSE:9987) Earnings Are A Poor Reflection Of Profitability

Recent updates

There Are Some Reasons To Suggest That Suzuken's (TSE:9987) Earnings Are A Poor Reflection Of Profitability

Nov 21
There Are Some Reasons To Suggest That Suzuken's (TSE:9987) Earnings Are A Poor Reflection Of Profitability

Analysts Are Updating Their Suzuken Co., Ltd. (TSE:9987) Estimates After Its Interim Results

Nov 17
Analysts Are Updating Their Suzuken Co., Ltd. (TSE:9987) Estimates After Its Interim Results

Do Suzuken's (TSE:9987) Earnings Warrant Your Attention?

Oct 28
Do Suzuken's (TSE:9987) Earnings Warrant Your Attention?

Calculating The Intrinsic Value Of Suzuken Co., Ltd. (TSE:9987)

Sep 05
Calculating The Intrinsic Value Of Suzuken Co., Ltd. (TSE:9987)

Subdued Growth No Barrier To Suzuken Co., Ltd.'s (TSE:9987) Price

Jul 11
Subdued Growth No Barrier To Suzuken Co., Ltd.'s (TSE:9987) Price

Here's Why We Think Suzuken (TSE:9987) Is Well Worth Watching

Jun 12
Here's Why We Think Suzuken (TSE:9987) Is Well Worth Watching

Shareholders Can Be Confident That Suzuken's (TSE:9987) Earnings Are High Quality

May 22
Shareholders Can Be Confident That Suzuken's (TSE:9987) Earnings Are High Quality

Investor Optimism Abounds Suzuken Co., Ltd. (TSE:9987) But Growth Is Lacking

Mar 22
Investor Optimism Abounds Suzuken Co., Ltd. (TSE:9987) But Growth Is Lacking

Revenue & Expenses Breakdown

How Suzuken makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

TSE:9987 Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 242,389,34433,410153,5970
30 Jun 242,395,04530,636151,8070
31 Mar 242,386,49329,016150,3730
31 Dec 232,371,22527,681148,9990
30 Sep 232,370,99025,379148,2350
30 Jun 232,334,71821,006148,2830
31 Mar 232,314,82820,345147,0890
31 Dec 222,306,58019,310148,2240
30 Sep 222,273,51316,065147,6180
30 Jun 222,247,38517,506146,8320
31 Mar 222,232,77414,393147,2160
31 Dec 212,205,19915,033146,1860
30 Sep 212,183,48712,694146,1380
30 Jun 212,150,7349,041146,9540
31 Mar 212,128,2187,895148,6830
31 Dec 202,133,97614,012151,9760
30 Sep 202,141,51919,394156,0930
30 Jun 202,183,54222,641159,1830
31 Mar 202,213,47828,213161,5520
31 Dec 192,214,47526,263161,6960
30 Sep 192,214,86134,177162,1390
30 Jun 192,159,35433,533162,1140
31 Mar 192,132,36230,204162,0660
31 Dec 182,111,24428,126162,3860
30 Sep 182,108,84720,925164,1450
30 Jun 182,115,93716,386165,5670
31 Mar 182,123,99718,820167,7750
31 Dec 172,130,45318,807170,7950
30 Sep 172,118,73121,894172,1770
30 Jun 172,121,76123,333173,3520
31 Mar 172,126,99321,308174,5130
31 Dec 162,186,66526,534175,5760
30 Sep 162,247,81026,403176,0480
30 Jun 162,251,83926,925175,5100
31 Mar 162,228,33128,960174,2190
31 Dec 152,149,12124,043171,5920
30 Sep 152,066,20421,320169,1180
30 Jun 152,017,82420,122167,5360
31 Mar 151,969,68918,920166,3900
31 Dec 141,977,29121,296167,0980
30 Sep 141,968,91120,219167,6560
30 Jun 141,968,81319,905167,3910
31 Mar 141,988,21621,447168,2160
31 Dec 131,952,02322,495165,9100

Quality Earnings: 9987 has a high level of non-cash earnings.

Growing Profit Margin: 9987's current net profit margins (1.4%) are higher than last year (1.1%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 9987's earnings have grown by 5.8% per year over the past 5 years.

Accelerating Growth: 9987's earnings growth over the past year (31.6%) exceeds its 5-year average (5.8% per year).

Earnings vs Industry: 9987 earnings growth over the past year (31.6%) exceeded the Healthcare industry 8.3%.

Return on Equity

High ROE: 9987's Return on Equity (7.8%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 21:08
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Suzuken Co., Ltd. is covered by 11 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Atsushi SekiBarclays
Ritsuo WatanabeBofA Global Research
Hidemaru YamaguchiCitigroup Global Markets Japan Inc.